broker commercial insurance topeka

Marketwire - Healthcare
Marketwire - Healthcare

• BC High School Students Empowered to Save Lives!
  VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 28, 2008) - The ACT Foundation, in partnership with the British Columbia Ambulance Service and the Ambulance Paramedics of British Columbia - CUPE Local 873, is thrilled to announce that 6,500 students in three BC school districts will be empowered to save lives each year, thanks to the Envision Credit Union Charitable Foundation. "I congratulate the ACT Foundation and their partners for promoting healthy living while empowering students to save lives," said Mary Polak, Minister of Healthy Living and Sport. "CPR is a life saving skill that I would encourage all British Columbians to learn."
• Open EC Technologies, Inc. Reports Record First Quarter, Fiscal 2009 Results With 49% Revenue Increase
  NORTH VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 28, 2008) - Open EC Technologies, Inc. (the "Company") (TSX VENTURE:OCE) announced today a new sales record with sales revenue for the first fiscal quarter increasing 49% from the same period of the previous fiscal year to $1,918,370 with EBITDA earnings of $222,431 for the period ended September 30, 2008. Highlights of the performance during the three months ended September 30, 2008 are as follows: - The revenues for the quarter were $1,918,370 with an EBITDA of $222,431 as compared with revenues of $1,286,584 and an EBITDA of $176,037 during the same period in the last fiscal year.
• Avis aux médias : Journée mondiale du sida 2008 - Une série de conférences de Médecins du Monde Canada
  MONTREAL, QUEBEC--(Marketwire - 28 nov. 2008) - Le docteur Marie Gessy Richard, coordinatrice générale des projets de Médecins du Monde Canada en matière de lutte au VIH/sida en Haïti et en République Dominicaine, sera de passage à Montréal du 1er au 5 décembre prochain. Tout au long de son séjour au Québec, le docteur Gessy Richard donnera une série de conférences portant sur l'intégration des soins en milieu hospitalier pour les personnes séropositives vivant dans les pays en développement. Elle s'inspirera de son expérience à Cité Soleil, en Haïti.
• Ergorecherche communique ses résultats financiers du premier trimestre 2009
  MONTREAL, QUEBEC--(Marketwire - 27 nov. 2008) - Ergorecherche Ltée "Ergorecherche" (TSX CROISSANCE:ERG) annonce les résultats financiers de son premier trimestre 2009. Ergorecherche poursuit sa lancée et annonce un bénéfice net de 62 590$ pour le premier trimestre de l'année financière 2009. Les ventes ont progressé de 24,5% en comparaison avec le même trimestre l'année dernière, pour se situer à 612 127$. Ergorecherche a vécu un retournement complet de situation depuis les dernières années, annonçant des années record consécutives. En effet, la société a annoncé des profits net de 423 247$ au 30 juin 2008, 210 111$ au 30 juin 2007 et de 159 502$ au 30 juin 2006. La société avait auparavant bénéficié de travaux de recherches importants pour lancer ses technologies brevetées.
• Ergoresearch Discloses First Quarter 2009 Financial Results
  MONTREAL, QUEBEC--(Marketwire - Nov. 27, 2008) - Ergoresearch Ltd "Ergoresearch" (TSX VENTURE:ERG) Ergoresearch continues the achievement of its business plan, by announcing profits of $62 590 for the first quarter of fiscal year 2009 compared to $21 236 for the same quarter last year. During this first quarter, sales amounted to $612 127, an increase of 24.5% compared to Q1-2008. Ergoresearch has witnessed a complete turnaround, delivering record years for the last years with profits of $423 247 for the year ended June 30, 2008, of $210 111 for the year ended June 30, 2007, and of $159 502 for the year ended June 30, 2006. The Company previously benefited from important research to launch its patented technologies.
• I-many Receives NASDAQ Notice of Non-Compliance
  

  EDISON, NJ--(Marketwire - November 26, 2008) - I-many, Inc. (NASDAQ: IMNY), a leading provider of contract management software and services for the enterprise, reported that on November 24, 2008, the Company received a NASDAQ Staff Determination indicating that the Company has not regained compliance with the minimum $35 million market value of listed securities requirement set forth in NASDAQ Marketplace Rule 4310(c)(3)(B) (the "Rule"). As a result, the Company's common stock would be subject to delisting unless the Company requests a hearing before the NASDAQ Listing Qualifications Panel (the "Panel"). I-many intends to request a hearing before the Panel. Consequently, I-many's common stock will remain listed on The NASDAQ Capital Market until the Panel renders a decision following the hearing. However, there can be no assurance that the Panel will grant I-many's request for continued listing.

• Aperture Health Appoints Ambassador Kevin E. Moley to Board of Directors
  

  MISSION VIEJO, CA--(Marketwire - November 26, 2008) - Aperture Health, Inc. (OTCBB: APRE) announced today that Ambassador Kevin Moley, a former Deputy Secretary of the U.S. Department of Health and Human Services in President George H.W. Bush's administration, has joined the Board of Directors of Aperture Health. Ambassador Moley also served as Assistant Secretary for Management and Budget of the U.S. Department of Health and Human Services. During the Reagan Administration, Ambassador Moley was the Chief Federal Regulator of the HMO industry and also was the Associate Administrator of Operations for Medicaid and Medicare. Most recently Ambassador Moley served as United States Ambassador to the U.N. in Geneva from September 2001 until May of 2006.

• Experts Discuss How Lessons Learned From British System of Foreign Aid Can Help Modernize and Improve Foreign Aid in the United States
  

  Panel Discussion Set for Wednesday, December 3, 3:30 to 5 PM, in Room 2200, Rayburn House Office Building, on Capitol Hill in Washington, D.C.

• MedaSorb Technologies' Board Member, Edward Jones M.D., Elected President of the Renal Physicians Association
  

  MONMOUTH JUNCTION, NJ--(Marketwire - November 26, 2008) - MedaSorb Technologies Corporation (OTCBB: MSBT) is pleased to recognize the election of its Director, Edward Jones M.D. to President of the Renal Physicians Association. Dr. Jones is an attending physician at Albert Einstein Medical Center and Chestnut Hill Hospital as well as Clinical Professor of Medicine at Temple University Hospital. Dr. Jones is currently president elect and will officially take over as president in 2009.

• Somatic Systems, Inc. National Television Show Airings Begin
  

  NORTHAMPTON, MA--(Marketwire - November 26, 2008) - Somatic Systems, Inc. (PINKSHEETS: SMAS) is pleased to announce that the first airings of the upcoming national television show featuring the company and its proprietary Clinical Somatics pain relief system, clinics, products, and training programs will begin next week. The television program will be the largest exposure for the company and its services so far, increasing Somatic Systems' audience from a population of tens of thousands to tens of millions.

• Intrinsyc Announces "Symbian Ready" Location-Based Services Validation for Its Destinator Navigation Software
  Destinator one of the first LBS applications to be certified as "Symbian Ready" in Symbian technology validation program
• Pharming announces positive results from Prodarsan(R) Phase I Study
  

  LEIDEN, NETHERLANDS--(Marketwire - November 26, 2008) -

  
  Key step in clinical program for ageing diseases

  Leiden, The Netherlands, November 26, 2008. Biotech company Pharming Group NV ("Pharming") (NYSE Euronext: PHARM) announced today that its wholly owned subsidiary DNage has successfully completed a Phase I trial, in healthy human volunteers, to evaluate the pharmacokinetics and tolerability of Prodarsan®.

  In this Phase I study, single and multiple escalating doses were administered to healthy volunteers. The data obtained show that Prodarsan® is safe and well tolerated when used in dosages that have earlier shown to yield positive effects in preclinical studies. Since Prodarsan® will be used as an oral, liquid formulation the effects of food intake on absorption and elimination of the product were also investigated. Based on these data, combi